Fungal growth inhibitory properties of new phytosphingolipid analogues

Journal of Applied Microbiology

Volumn 104, Issue 4, 2008, Pages 1075-1081

  Mormeneo, D ^a,b   Manresa, A ^a   Casas, J ^b   Llebaria, A ^b   Delgado, A ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

Analogues; Antifungal; Phytoceramide; Phytosphingosine

Indexed keywords

ASPERGILLUS;

ANALOG; ANTIFUNGAL ACTIVITIES; ANTIFUNGALS; ASPERGILLUS NIGER; CANDIDA ALBICANS; FUNGAL GROWTH; PHYTOCERAMIDE; PHYTOSPHINGOLIPIDS; PHYTOSPHINGOSINES; PROPERTY;

YEAST;

CERAMIDE DERIVATIVE; MICONAZOLE; PHYTOCERAMIDE DERIVATIVE; PHYTOSPHINGOSINE DERIVATIVE; SPHINGOLIPID; UNCLASSIFIED DRUG;

COMPARATIVE STUDY; CONCENTRATION (COMPOSITION); FUNGUS; GROWTH RATE; INHIBITION; LIPID; YEAST;

ANTIFUNGAL ACTIVITY; ARTHRODERMA; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CLADOSPORIUM; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM CHRYSOGENUM; SACCHAROMYCES CEREVISIAE; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

ARTHRODERMA UNCINATUM; ASPERGILLUS NIGER; ASPERGILLUS REPENS; CANDIDA ALBICANS; CLADOSPORIUM CLADOSPORIOIDES; PENICILLIUM CHRYSOGENUM; PENICILLIUM FUNICULOSUM; SACCHAROMYCES CEREVISIAE; SPHINGOIDEA;

EID: 40849097714     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2007.03635.x     Document Type: Article

References (30)

1. Ampel, N.M. (1996) Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis 2, 109 116.
2. Bow, E.J. (1998) Invasive fungal infections in patients receiving intensive cytotoxic therapy for cancer. Br J Haematol 101 (Suppl. 1 1 4.
3. Brace, J.L., Lester, R.L., Dickson, R.C. Rudin, C.M. (2007) SVF1 regulates cell survival by affecting sphingolipid metabolism in Saccharomyces cerevisiae. Genetics 175, 65 76.
4. Brown, J.M. (2004) Fungal infections in bone marrow transplant patients. Curr Opin Infect Dis 17, 347 352.
5. Castagnola, E., Cesaro, S., Giacchino, M., Livadiotti, S., Tucci, F., Zanazzo, G., Caselli, D., Caviglia, I., Parodi, S., Rondelli, R., Cornelli, P.E., Mura, R., Santoro, N., Russo, G., De Santis, R., Buffardi, S., Viscoli, C., Haupt, R. Rossi, M. R. (2006) Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J 25, 634 639.
6. Clark, R. J., Garson, M. J. Hooper, J. N. (2001) Antifungal alkyl amino alcohols from the tropical marine sponge Haliclonan sp. J. Nat. Prod. 64, 1568 1571.
7. Claus, R., Russwurm, S., Meisner, M., Kinscherf, R. Deigner, H. P. (2000) Modulation of the ceramide levels, a novel therapeutic concept? Curr. Drug Targets 1, 185 205.
8. Chamilos, G. Kontoyiannis, D.P. (2005) Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug Resist Updat 8, 344 358.
9. Cheng, J., Park, T.S., Chio, L.C., Fischl, A.S. Ye, X.S. (2003) Induction of apoptosis by sphingoid long-chain bases in Aspergillus nidulans. Mol Cell Biol 23, 163 177.
10. Chung, N., Jenkins, G., Hannun, Y.A., Heitman, J. Obeid, L.M. (2000) Sphingolipids signal heat stress-induced ubiquitin-dependent proteolysis. J Biol Chem 275, 17229 17232.
11. Chung, N.C., Mao, C., Heitman, J., Hannun, Y.A. Obeid, L.M. (2001) Phytosphingosine as a specific inhibitor of growth and nutrient import in Saccharomyces cerevisiae. J Biol Chem 276, 35614 35621.
12. Espinel-Ingrof, A.V., Pfaller, M.A., Baron, E.J., Jorgensen, J.H. Yolken, R.H. (2003) Susceptibility test methods: Yeast and filamentous fungi. In Manual of Clinical Microbiology ed. Murray, P.R., Baron, E.J., Pfaller, M.A., Jorgensen, J.H. Yolken, R.H. pp. 1880 1893. Washington, USA : ASM Press.
13. Fishbein, J.D., Dobrowsky, R.T., Bielawska, A., Garrett, S. Hannun, Y.A. (1993) Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae. J Biol Chem 268, 9255 9261.
14. Fishman, J.A. (2002) Overview: fungal infections in the transplant patient. Transpl Infect Dis 4 (Suppl. 3 3 11.
15. Hakomori, S. (1990) Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265, 18713 18716.
16. Klepser, M.E. (2006) Candida resistance and its clinical relevance. Pharmacotherapy 26, 68S 75S.
17. Kolter, T. Sandhoff, K. (1999) Sphingolipids - Their metabolic pathways and the pathobiochemistry of neurodegenerative diseases. Angew Chem Int Ed Engl 38, 1532 1568.
18. Liu, K., Zhang, X., Lester, R.L. Dickson, R.C. (2005a) The Sphingoid long chain base phytosphingosine activates AGC-type protein kinases in Saccharomyces cerevisiae including Ypk1, Ypk2, and Sch9. J Biol Chem 280, 22679 22687.
19. Liu, K., Zhang, X., Sumanasekera, C., Lester, R.L. Dickson, R.C. (2005b) Signalling functions for sphingolipid long-chain bases in Saccharomyces cerevisiae. Biochem Soc Trans 33, 1170 1173.
20. Marr, K.A. Bowden, R.A. (1999) Fungal infections in patients undergoing blood and marrow transplantation. Transpl Infect Dis 1, 237 246.
21. Mormeneo, D. (2007) Chemical modifications on phytosphingolipids. Synthesis and biological studies. Thesis. Research Unit on Bioactive Molecules (IIQAB-CSIC, Barcelona) and University of Barcelona, Barcelona.
22. Nenoff, P. Haustein, U.F. (2002) In vitro activity of phytosphingosines against Malassezia furfur and Candida albicans. Acta Derm Venereol 82, 170 173.
23. Nicholas, G.M., Li, R., MacMillan, J.B. Molinski, T.F. (2002) Antifungal activity of bifunctional sphingolipids. Intramolecular synergism within long-chain alpha,omega-bis-aminoalcohols. Bioorg Med Chem Lett 12, 2159 2162.
24. Samaranayake, L.P., Fidel, P.L., Naglik, J.R., Sweet, S.P., Teanpaisan, R., Coogan, M.M., Blignaut, E. Wanzala, P. (2002) Fungal infections associated with HIV infection. Oral Dis 8 (Suppl. 2 151 160.
25. Searle, P.A. Molinski, T.F. (1993) Structure and absolute-configuration of (R)-(E)-1-aminotridec-5-en-2-ol, an antifungal amino alcohol from the Ascidian didemnum sp. J Org Chem 58, 7578 7580.
26. Skrzypek, M.S., Nagiec, M.M., Lester, R.L. Dickson, R.C. (1998) Inhibition of amino acid transport by sphingoid long chain bases in Saccharomyces cerevisiae. J Biol Chem 273, 2829 2834.
27. Sud, I.J. Feingold, D.S. (1981) Heterogeneity of action of mechanisms among antimycotic imidazoles. Antimicrob Agents Chemother 20, 71 74.
28. Sugimoto, Y., Sakoh, H. Yamada, K. (2004) IPC synthase as a useful target for antifungal drugs. Curr Drug Targets Infect Disord 4, 311 322.
29. Thevissen, K., Francois, I.E., Aerts, A.M. Cammue, B.P. (2005) Fungal sphingolipids as targets for the development of selective antifungal therapeutics. Curr Drug Targets 6, 923 928.
30. Woods, G.L. Washington, J.A. (1995) Antimicrobial Agents and Susceptibility Testing. In Manual of Clinical Microbiology ed. Murray, P.R., Baron, E.J., Pfaller, M.S., Ternover, F.C. Yolken, R.H. pp. 1327 1341. Washington, DC : ASM press.